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Deanna L. Mendez‡, Rebecca E. Mandt§, and Sarah C. R. Elgin‡1
From the ‡Department of Biology, Washington University, Saint Louis, Missouri 63130 and §Grinnell College,
Grinnell, Iowa 50112
Background: HP1a (Heterochromatin Protein 1a) discriminates among its partners, binding HP2 66-fold more tightly than
PIWI.
Results: Leu-165 on the HP1a binding surface provides a contact site for HP2 that PIWI does not utilize.
Conclusion: The Leu-165 contact is critical for HP1a’s partner discrimination.
Significance: Learning how HP1a selects its partners will help elucidate the function of HP1a in epigenetics.
Drosophila melanogaster Heterochromatin Protein 1a
(HP1a) is an essential protein critical for heterochromatin
assembly and regulation. Its chromo shadow domain (CSD)
homodimerizes, a requirement for binding protein partners that
contain a PXVXL motif. How does HP1a select among its many
different PXVXL-containing partners? HP1a binds tightly to
Heterochromatin Protein 2 (HP2), but weakly to PIWI. We
investigated differences in homodimerization and the impact of
the C-terminal extension (CTE) by contrasting HP1a to its paralogue, HP1b. HP1a and HP1b differ in the dimerization interface, with HP1a having an Arg at position 188 rather than Glu.
We find that while this substitution reduces the dimerization
constant, it does not impact the binding surface as demonstrated by unchanged partner binding affinities. However, the
CTE (only 4 residues in HP1a as compared with 87 residues in
HP1b) is critical; the charged residues in HP1a are necessary for
tight peptide binding. Examining a panel of amino acid substitutions in the HP1a CSD, we find that Leu-165 in HP1a interacts
with HP2 but not PIWI, supporting the conclusion that different
sites in the binding surface provide discrimination for partner
selection. Partner sequence is also critical for affinity, as the
remaining difference in binding between HP2 and PIWI polypeptides is eliminated by swapping the PXVXL motifs between
the two. Taken together, these studies indicate that the binding
surface of the HP1a CSD plus its short CTE provide the needed
discrimination among HP1a’s partners, and that the CTE is
important for differentiating the interactions of the Drosophila
HP1 paralogs.
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Heterochromatin Protein 1 (HP1a)2 was first discovered in
Drosophila melanogaster as a protein that localizes to the chromocenter, telomeres, and the fourth chromosome, all heterochromatic domains, as shown by immunofluorescent staining
of polytene chromosomes (1, 2). Subsequent genetic analysis
demonstrated that HP1a plays a critical role in heterochromatin formation, acting as a suppressor of variegation (showing
loss of silencing of a heterochromatic reporter) when mutant
(3). Four additional paralogs of HP1a are found in D. melanogaster: HP1b, HP1c, HP1d/Rhino, and HP1e (4). These proteins
share an N-terminal chromodomain (CD) followed by a variable length hinge, a chromo shadow domain (CSD), and a variable length C-terminal extension (CTE). They do not, however,
share target sites in the genome, as shown by their localization
patterns (5–7). HP1a, HP1b, and HP1c all function in the
somatic nucleus, while HP1d and HP1e are limited to the germline (4). Cytological analyses show that while HP1a is located
primarily in heterochromatic domains, HP1c is primarily associated with euchromatic domains, and HP1b overlaps both (6).
These distinctive distributions have been confirmed and
mapped at higher resolution by ChIP-chip analysis (7). Thus
while the recognizable domains, CD and CSD, are conserved,
and the genes are all expressed in somatic cells, the HP1a,
HP1b, and HP1c paralogs all have unique distributions and
functions in the genome.
The chromo shadow domains of HP1a and HP1b share 58%
sequence identity, whereas those of HP1a and HP1c share only
36% identity (8). All three proteins are predicted to dimerize (9).
The chromo shadow domain, which can function independently of the chromo domain (10), plays a role in determining the
genomic distribution patterns of the HP1 (6). To understand
better what differences in the chromo shadow domain impart
the differential roles of these proteins, we have compared the
dimerization and partner binding properties of HP1a with
those of HP1b.

2

The abbreviations used are: HP1a, heterochromatin protein 1a; CSD,
chromo shadow domain; CTE, C-terminal extension; CD, chromodomain;
WOC, without children.
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CSD function is regulated not only by amino acid sequence,
but also through its concentration. Concentration will determine the quantity of CSD dimers, and hence the quantity of
partner protein binding sites, present in a certain location.
HP1a is estimated to be present at micromolar concentrations
in the nucleus (11). It dimerizes with a dissociation constant of
3.0 ⫾ 0.2 M (12). A phosphorylation mimic of the HP1a CSD,
created by substituting glutamic acid for serine at residues 199
and 202, sites that appear constitutively phosphorylated (13),
has an even weaker dimerization affinity (KD ⫽ 19 ⫾ 1 M) (12).
We have proposed that a protein partner such as HP2, which
binds with higher affinity than the dimerization constant, could
“drive dimerization” by shifting the equilibrium from monomers of HP1a (84.5% in the absence of partner) to dimers. The
HP1a orthologue in human and mouse, HP1␤, was estimated to
dimerize at a dissociation constant of 150 nM (14). If it is present
in the mammalian nucleus at a concentration similar to that of
HP1a in the fly nucleus, HP1␤ likely exists as a constitutive
dimer in the cell. Swi6, the yeast Schizosaccharomyces pombe
orthologue of HP1a, has been found to have a dimerization
constant of about 17 nM (15), consistent with a constitutive
dimer in the yeast nucleus. Partner binding under these circumstances would not alter the dimerization of HP1␤ or Swi6
(unless phosphorylation weakened the dimerization significantly). Thus it is of interest to understand why HP1a has a
weaker dimerization interface, how the other somatic HP1a
paralogs compare in dimerization properties, and what the
implications might be for partner protein interaction.
Peptides from two HP1a-interacting nuclear proteins, Heterochromatin Protein 2 (HP2) and PIWI, have been used here
because of their different binding characteristics; in some cases
WOC (without children) was used as well, as it contains a peptide with a canonical PXVXL motif. HP2 colocalizes extensively
with HP1a in heterochromatin; mutations resulting in loss of
HP2 are suppressors of position effect variegation, resulting in
loss of silencing of heterochromatin reporters (16). The stoichiometric response observed with different doses of the gene, and
the lack of any enzymatic motifs, suggest that HP2 is a structural component of heterochromatin (Shaffer, Cenci et al.
2006). PIWI and HP1a are suggested to function together in
germline heterochromatin formation (17). While both HP2 and
PIWI contain the PXVXL pentapeptide HP1a binding motif
(18), HP1a:HP2 binding is 66-fold stronger than HP1a:PIWI
binding, the latter being typical of proteins with the PXVXL
motif (12). The weaker association of HP1b with heterochromatin suggests that it may not bind HP2 as effectively. To begin
to understand some of the features of HP1a that give it its
unique distribution and partner interactions, we have 1) analyzed its dimerization properties compared with those of HP1b,
and 2) used mutagenesis to determine the amino acids responsible for tight HP2 binding, in contrast to weak PIWI binding, to
the chromo shadow domain. Our results demonstrate that the
amino acid sequence of the binding partner together with the
HP1a binding surface determines the strength of interaction.

EXPERIMENTAL PROCEDURES
Cloning/Site-directed Mutagenesis—D. melanogaster HP1bCSD (residues 83–160) and HP1b-CSD-CTE (residues 83–240)

22316 JOURNAL OF BIOLOGICAL CHEMISTRY

were cloned into pET11a with restriction sites NdeI and
BamHI. HP1a constructs are derived from D. melanogaster
HP1a-CSD-CTE (residues 141–206) in pET 11a. In both HP1a
and HP1b constructs, two Lys residues precede a 6-histidine tag
at the N terminus, and the gene sequence is appended by two
additional Lys residues at the C terminus. The Lys residues have
been introduced to enhance solubility, while the 6-His tag is
used for purification.
QuikChange PCR mutagenesis was used with the enzyme
PfuUltra II Fusion HS DNA Polymerase. Mutagenesis was carried out using a two-step procedure. First a linear amplification
was performed using only one of the two primers for 8 cycles.
Then a logarithmic amplification was performed after mixing
half of each reaction mix from the linear amplification together
for 18 cycles (19). The PCR cycling conditions are based on the
manufacturer’s recommendations (Agilent Technologies).
Protein Expression—HP1a and HP1b constructs in pET11a
were transformed into Escherichia coli BL21 cells. Cells were
grown in lysogeny broth from an overnight starter culture 1:500
dilution to an optical density of 0.6 at 37 °C. The culture was
then induced to express the transformed gene with 1 M IPTG,
typically for 22 h at room temp (20 °C). Cells were then harvested by centrifugation (4424 ⫻ g for 10 min) and frozen
(⫺20 °C).
Protein Purification—Frozen cells from 2 liters of culture
were resuspended in lysis buffer (50 mM phosphate pH 8.0, 0.5
M NaCl, 20 mM imidazole, 0.5 M benzamidine, 0.5 M PMSF). The
suspension was mixed in a glass beaker with stirring and cooled
using ice while being sonicated for two 15-min intervals of 15 s
pulses and 15 s rests, with a 5 min rest between intervals. The
lysate was spun down in an Optima L-80 XP Ultracentrifuge in
a 45Ti rotor at 45,000 rpm for 45 min (Beckman Coulter). The
supernatant was subsequently loaded on to a 2– 4 ml of NiNTA column (Qiagen), and washed with 1L of wash buffer (50
mM phosphate, pH 8.0, 500 mM NaCl, 25 mM imidazole). The
protein was eluted with elution buffer (50 mM phosphate, pH
8.0, 150 mM NaCl, 250 mM imidazole).
Fluorescence Polarization Binding Assays—Fluorescence
polarization binding assays were carried out in a binding buffer
(50 mM phosphate, pH 8.0 and 150 mM NaCl). The total concentration of protein was typically 270 M as determined by UV
absorbance at 280 nm using the HP1a-CSD-CTE extinction
coefficient of 8480 M⫺1 cm⫺1, HP1b-CSD extinction coefficient
of 12490 M⫺1 cm⫺1, and HP1b-CSD-CTE extinction coefficient
of 12490 M⫺1 cm⫺1. Beginning with 300 l of the concentrated
protein sample, a serial dilution of 12 total samples was prepared, 150 l each. To these samples 1 l of 22 M fluoresceinated peptide was added to obtain a final peptide concentration
of 150 nM (12, 20). Samples were incubated at 15 °C, and their
polarization measured in a Beacon 2000 Variable Temperature
Fluorescence Polarization System (Invitrogen).
Calculation of Binding Affinities—The concentration of
HP1a dimers was calculated based on the KD determined by
AUC. That percentage was multiplied by the total protein concentration and then divided by 2 to obtain the concentration of
dimer sites available for binding. That concentration was plotted as a function of the fraction of peptide bound (20). A oneto-one binding model was used to fit the data (20) and deterVOLUME 288 • NUMBER 31 • AUGUST 2, 2013
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FIGURE 1. The dimerization interface of HP1a-CSD-CTE has undergone a recent change that reduces its stability. A, multiple sequence alignment of the
chromo shadow domains of Drosophila HP1a, HP1b, HP1c, Human/Mouse HP1␤, and yeast Swi6. Residues with a blue triangle above them are found in the
dimerization interface (9, 12). Residues with a rectangle above or around them were mutated in this study. Brown rectangles: residues important for differences
in partner binding observed between HP1a and HP1b. Blue rectangles: mutation impacts chromoshadow domain folding. Red rectangle: mutation has a
differential impact on HP2 and PIWI binding in HP1a. Boxed residue: mutation has an impact on CSD dimer stability. Residues that are underlined indicate the last
residue of the peptide used for analytical ultracentrifugation (AUC) studies. HP1a sequence from the CSD to the end was used since the last three residues
improve its affinity. This length is comparable to that used for HP1b, HP1␤, and Swi6. B, top: the crystal structure of Dm HP1a (1s4z) with Arg-188 highlighted
together with its pairing amino acid Glu-184. Bottom: the crystal structure of HP1␤ highlighting the position of Gln-188 (numbering of Dm) and its interacting
amino acid Asn-183. C, data collected from equilibrium AUC of HP1a-CSD-CTE-R188Q showing that a monomer/dimer fit to the Lamm equation approximates
that data well, as judged by the random distribution of the residuals about the mean.

mine the dissociation constant using Kaleidagraph (Synergy
Software). Error reflects 95% confidence intervals of the curve
fit.
Fluoresceinated Peptides—HP2 and PIWI peptides were generated by the Yale University Keck Facility. Fluorescein was
added to the N terminus of the following peptides: HP2 peptide
Cys to Ser mutant used for all assays: NH2-QNISPRKLSVKINRRPYNKWLR-COOH, HP2 peptide with PIWI pentamer:
NH2-QNISPRKPRVKVNRRPYNKWLR-COOH, PIWI peptide:
PIWI NH2-TSRGSGDPRVKVFRGSSSGDY-COOH, PIWI peptide with HP2 pentamer: NH2-TSRGSGDLSVKIFRGSSSGDYCOOH.
Circular Dichroism—The protein secondary structure was
assessed by circular dichroism with a Jasco J-815 spectrometer
at a scan speed of 50 nm/min and temperature of 15 °C. The
data pitch was 0.2 nm, the bandwidth 1 nm, and the response
time 1 s, with a continuous scanning mode. The protein samples were 20 M in binding buffer (50 mM phosphate, pH 8.0
and 150 mM NaCl).
Gel Filtration—Gel Filtration was performed on a Superdex
75 column (GE Healthcare Life Sciences). A 50 l sample was
loaded on the column in binding buffer (50 mM phosphate, 150
mM NaCl, pH 8.0). The sample concentrations were HP1aAUGUST 2, 2013 • VOLUME 288 • NUMBER 31

CSD-L147K, 92 M; -L153K 167 M; -L165K 114 M; -V171K
99 M; -V177A 260 M; -V181K 71 M; -E205Q 198 M; and
-D206N 106 M.
Analytical Ultracentrifugation—HP1a-CSD-CTE-R188Q was
prepared in binding buffer (50 mM phosphate pH 8.0, 150 mM
NaCl) at 6 different concentrations ranging from 5–91 M. Samples were spun at 25, 35, and 45 krpm until equilibrium was
reached as judged by two scans separated by 2 h overlaying each
other. Equilibrated curves were analyzed using Ultrascan (21). The
molecular mass of HP1a-CSD-CTE-R188Q is 9989 Da. When performing a global analysis of the equilibrium AUC data, the molecular mass was fixed to that value, and the equilibrium constant fit
to the data.
The same procedure was followed with HP1b-CSD (5– 60
M) and HP1b-CSD-CTE (3.5– 60 M). The extinction coefficient for both samples is 12490 M⫺1 cm⫺1, and their respective
molecular masses are 9711 Da and 17,281 Da. HP1b-CSD was
spun at 25, 35, 45 krpm and HP1b-CSD-CTE at 15, 25, 35 krpm.
1 mM TCEP was included in the binding buffer for both HP1b
samples. The error analysis was performed using a Monte Carlo
simulation, estimating an error of 8% to ensure that we were
sampling possible equivalent fits; 95% confidence intervals
were obtained.
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 2. Peptide binding to HP1a-CSD-CTE-R188Q is not altered from
WT. Fluorescence Polarization data of HP1a-CSD-CTE WT and the R188Q
mutant binding to PIWI or HP2. The fraction of peptide bound is plotted as a
function of HP1a-CSD-CTE dimer. Below is a table of the Kd values of the peptides binding to the WT or R188Q mutant.

RESULTS
The D. melanogaster Dimerization Interface of HP1a Is
Weaker Than That of Several Homologues—We previously
determined the crystal structure of the HP1a chromo shadow
domain, and found that the dimerization interface composed of
nine residues (Fig. 1A) (12). Seeking to understand the relatively
weak dimerization constant, we compared the critical residues
with those of HP1␤. Among them, Arg-188 and Ser-199 in Drosophila (numbering from Dm) are not identical to the mouse/
human sequence, where the corresponding residues are Gln
and Thr (Fig. 1A). The structure of HP1␤ (PDB 2FMM) (22)
indicates that there is a hydrophobic interaction between Gln188 and Asn-183, while the structure of HP1a (PDB 3P7J) (12)
indicates that R188 forms an electrostatic interaction with the
neighboring residue Glu-184 (Fig. 1B). Given this structural
information, and noting that the difference between Arg and
Gln is the more significant change (compared with a Ser to Thr
change), we investigated the contribution of this residue to the
stability of the dimer. A Gln at this position is more common
among the HP1 homologues (Fig. 1A); the substitution of an
Arg appears to be a change exclusive to the Drosophila family
(melanogaster, schelia, and simulans).3
To elucidate the contribution of Arg-188 toward the
dimerization dissociation constant of HP1a, we mutated this
residue to Gln. This recombinant HP1a chromo shadow
domain expressed well and eluted as a single peak on the size
exclusion column Superdex 75, similar to the WT construct.
Interestingly, as measured by equilibrium analytical ultracentrifugation (AUC), there is a 2.4-fold improvement in the
dimerization constant (Fig. 1C). HP1a R188Q has a dimerization constant in the high nanomolar range. Thus the difference

3

N. C. Riddle and I. Umana, Washington University, personal communication.
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FIGURE 3. HP1b chromo shadow domain self-association is opposed by
its 87 residue C-terminal extension. A, domain diagram of HP1a and HP1b.
The chromoshadow domain construct for HP1b extends from residue 92 to
160. B and C, global analysis of HP1b-CSD (B) and HP1b-CSD-CTE (C) by equilibrium AUC. A monomer/dimer fit to the Lamm equation approximates that
data well, as judged by the random distribution of the residuals about the
mean (upper panels; raw data in the lower panels), and shows weaker
dimerization in the presence of the C-terminal extension.

in dimerization constants between HP1a and HP1␤ is largely
explained by this difference in amino acid sequence.
To determine the impact that this mutation has on partner
binding, we performed fluorescence polarization assays with
three peptides derived from chromo shadow domain binding
partners. WOC (without children), which co-precipitates with
HP1c (23, 24), has a canonical PXVXL sequence (PHVLL, cenVOLUME 288 • NUMBER 31 • AUGUST 2, 2013

HP1a Partner Specificity

FIGURE 4. The HP1b carboxyl tail extension enhances chromo shadow
domain discrimination in some cases. Fluorescence Polarization data of
HP1b-CSD and HP1b-CSD-CTE binding to WOC. A table of the Kd values for
WOC and HP2 peptides binding to HP1b-CSD or HP1b-CSD-CTE is shown
below.

tered on Val-1538, which we refer to as position 0); HP2 has a
non-canonical PXVXL sequence (LSVKI, centered on Val2468); and PIWI has a near-canonical sequence, but lacks large
hydrophobic residues in the plus or minus 2 position (PRVKV,
centered on Val-30). We found no change in the dissociation
constant on binding to WT or R188Q HP1a dimers (Fig. 2),
indicating that this modest shift in dimerization does not affect
Dm HP1a’s ability to interact with its partners. (Note that the
change is not near the binding surface.) This is in contrast to the
effects observed when the dimer is abolished with the I191E
substitution, or when the PXVXL binding surface is disrupted
with the W200A substitution (12).
HP1b CSD Exhibits Tighter Dimer Formation, Which Is
Reduced by the 87 Residue CTE—HP1b shares all of its residues
in the dimerization interface with mouse/human HP1␤. Unlike
HP1␤, however, it has an 87 residue CTE. Our previous study of
HP1a showed that the chromo shadow domain with the C-terminal extension has the same dimerization constant as was
found for the full-length protein, indicating that the chromo
shadow domain acts independently of the chromodomain and
hinge regions that are N-terminal to it. Since our previous
investigation of HP1a indicated a 0.7-fold tighter affinity for the
chromo shadow domain per se, compared with when the CTE
(4 residues) were included, we performed equilibrium AUC on
HP1b chromo shadow domain with and without its CTE (Fig.
3A). We find that the chromo shadow domain alone (aa
87–160; see Fig. 3A) has a dimerization constant of less than 50
nM (Fig. 3B), which more closely resembles what is found for
HP1␤ and Swi6 rather than HP1a. The HP1b chromo shadow
domain with the full CTE exhibits a significantly reduced
dimerization constant of 5.2 ⫾ 0.2 M (Fig. 3C). This weakened
dimerization in the presence of the CTE suggests that in vivo,
HP1b is similar to HP1a, in that peptide binding could influence
dimerization.
HP1a and HP1b are both predicted to bind PXVXL containing sequences (9), and it is of interest to compare their affinity
AUGUST 2, 2013 • VOLUME 288 • NUMBER 31

FIGURE 5. HP1a CTE charged residues enhance binding of both HP2 and
PIWI. A and B, fluorescence Polarization data assessment of HP1a-CSD-CTE
WT binding of HP2 (A) or PIWI (B) compared with that of CSD mutations E205Q
or D206N. The fraction of peptide bound is plotted as a function of HP1a-CSDCTE dimer. C, table of the KD values of the peptides binding to the WT, E205Q,
or D206N forms of HP1a-CSD-CTE. Loss of either charged residue in the CSD
results in weaker binding of both peptides.

for a variety of partners. We found that the WOC peptide, with
an exact PXVXL sequence, bound with highest affinity to the
HP1b CSD, with a KD of 1.98 ⫾ 0.16 M, while the HP2 peptide
bound with a KD of 5.2 ⫾ 0.5 M. In the presence of the CTE the
affinity of WOC decreased (3.2-fold) (Fig. 4) while there was no
change in HP2 affinity. Thus the presence of the CTE reduces
dimerization propensity, and enhances the ability of the HP1b
chromo shadow domain to discriminate among potential partners. We find that the binding of HP2 to HP1b is about 10-fold
weaker than its binding to HP1a.
Weaker HP1b Peptide Binding May Reflect a Difference in
CTE Interactions—58% of the residues in the chromo shadow
domain of HP1a and HP1b are identical, but their CTEs are
entirely different. In HP1a, CTE residues 203, 205, and 206 are
negatively charged, whereas the corresponding residues in
HP1b are neutral. Since deleting HP1a’s last three residues (the
JOURNAL OF BIOLOGICAL CHEMISTRY
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CTE) had an impact on both HP2 and PIWI binding (12), we
wondered whether the charge present in these residues contributed to the difference observed between HP1a and HP1b
binding to HP2 and PIWI. To test the impact of charged CTE
residues on partner binding, we made charge neutralization
mutations in HP1a-CSD-CTE, changing E205Q and D206N.
These mutations did not significantly alter the secondary structure of HP1a-CSD-CTE or its ability to dimerize (25), but they
both significantly reduced binding to each peptide from 2.2–
4.6-fold (Fig. 5). In contrast, HP1b-CSD-CTE showed weaker
binding of the WOC peptide, with no appreciable change in
HP2 peptide binding, in comparison to HP1b-CSD (Fig. 4).
A Hydrophobic Patch on the CSD Impacts HP1a Secondary
Structure and Peptide Binding—To determine how the residues
in the chromo shadow domain surface participate in peptide
discrimination, contributing to the very effective binding of
HP2 by HP1a, we created a panel of mutations in the HP1a
binding surface. Because the binding affinity of HP2 or PIWI to
HP1a-CSD-CTE changes very little under different salt concentrations (25, 150, 500 mM NaCl) (data not shown), we tested
hydrophobic residues as a potential source of discrimination
between HP2 and PIWI peptide binding (L147K, L153K,
V177A, V181K) (Fig. 6, A–D). However, we found that these
mutations all result in perturbation of the structure of the
chromo shadow domain and induce aggregation (Fig. 6E). We
anticipated that mutations in residues such as Leu-147 and Val177, which were previously identified to be important for the
fold (tertiary structure) of the chromo shadow domain (9),
would potentially impact the secondary structure (Figs. 1 and
6A). However, we also observed that residues Leu-153 and Val181, which were not previously identified as being important
for tertiary structure, are important for proper folding (Fig. 6E).
In all of these cases, although the data suggest a weakened affinity for the HP2 and PIWI peptides (Fig. 6, B and C), the actual
binding affinity cannot be determined because there is a lack of
homogeneous, well-folded HP1a protein as a result of these
mutations.
HP2 Peptide but Not PIWI Interacts with Leu-165—Leu-165
along with Met-176 and Ser-156 have been identified as a site of
interaction for residues ⫺7/⫺6 and ⫹5/⫹6 away from the central Val in the partner protein (9). Leu-165 is the only residue
among these to be absolutely conserved among D. melanogaster HP1a, HP1b, and mouse/human HP1␤. We also note
that the HSQC map of HP1a in the presence of HP2 exhibits a
split peak at Leu-165, indicating that each Leu-165 in the
homodimer engages in a distinct interaction with the HP2 peptide. In contrast, binding by PIWI results in a single Leu-165
shifted peak, indicating a less specific response of this residue to
the bound peptide (12). Following mutation of Leu-165 to Lys,
fluorescence polarization binding assays showed that HP2 has a

FIGURE 6. HP1a-CSD-CTE mutations L147K, L153K, V177A, and V181K all
cause a decrease in binding to both HP2 and PIWI concomitant with a
change in secondary structure. A, crystal structure of HP1a-CSD-CTE (PDB

22320 JOURNAL OF BIOLOGICAL CHEMISTRY

3P7J). WT residues that were mutated are shown as dotted spheres. B and C,
fluorescence polarization binding curves for HP2 (B) and PIWI (C) for the WT
and mutant forms of the HP1a-CSD-CTE. The fraction of peptide bound is
plotted as a function of HP1a-CSD-CTE dimer. D, table of the KD values of the
peptides binding to HP1a-CSD-CTE WT or mutated forms. E, circular dichroism far-UV spectra of HP1a-CSD-CTE WT and mutants V147, V153, V177, and
V181. These mutants exhibit a change in their CD spectrum that indicates a
change in secondary structure relative to WT.

VOLUME 288 • NUMBER 31 • AUGUST 2, 2013
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22-fold reduction in affinity for HP1a, while PIWI shows a 1.6fold change in affinity (Fig. 7). In contrast, mutation of Val-171,
located in a loop that connects the ␤2 and ␤3 domains (Fig. 1A),
has a 1.2–1.6-fold impact on either HP2 or PIWI binding to
HP1a. Neither mutation significantly alters secondary structure (analyzed by circular dichroism, Fig. 7E) or induces aggregation (25). Thus Leu-165 gives HP1a the ability to form a more
stable interaction with a specific subset of its partners.
The PXVXL Pentamer of the Binding Partner Has an Important Role—Previously we found that the LXVXI motif in HP2
contributes to HP2 tight binding, but swapping this pentamer
into the PIWI peptide does not change its affinity significantly
(12). To test whether the remaining enhanced affinity of the
HP2 polypeptide is due to its pentamer sequence (the PXVXL
motif), we swapped those sequences between HP2 and PIWI
and measured the binding to the HP1a-L165K mutant. Under
these circumstances, the affinity of both the HP2 and PIWI
peptides decreases to the same value within the error, 15 ⫾ 2
M versus 14.1 ⫾ 1.4 M (Fig. 8). Thus, the pentamer sequence
in HP2, LSVKI, and the contact with the HP1a residue Leu-165,
are sufficient to account for the difference in binding between
HP2 and PIWI. This result argues that both binding of the central PXVXL sequence and interactions at the flanking residues
tune selectivity and stability of HP1a complexes.

DISCUSSION
In this study we explore how HP1 paralogues achieve unique
functions in the genome by examining their ability to bind to
unique partners. To help elucidate their ability to discriminate
among partners, we have examined the binding surface of
HP1a in greater detail. This binding surface is created by
homodimerization. We identified two of nine residues in the
dimerization interface that could be involved in differential regulation of dimerization, residues that are not conserved in
HP1a in comparison with Mm/Hs HP1␤ and Dm HP1b: Arg188 and Ser-199. Residue 188 is a conserved glutamine in HP1b,
HP1c and Mm/Hs HP1␤ while residue 199 is more variable
among the Dm HP1a family. Consequently we focused on Arg188, and found that the R188Q substitution does improve HP1a
dimer stability (Fig. 1). However, this change does not impact
partner binding (Fig. 2). Because the dimerization parameters
did not provide much insight into the mechanism for CSD differential partner binding, we next looked at the binding surface
of the CSD.
Our previous study showed that the CTE was important for
HP1a tight binding to both of the tested peptides, HP2 and
PIWI (12). This indicated that the CTE might be part of the
HP1a binding surface. HP1a and HP1b differ in the length and
sequence of their CTEs. HP1a has a short, negatively charged
CTE of just five residues whereas HP1b has a CTE of ⬃80 residues, with neutral residues in positions where the HP1a CTE
has charged residues. Mutations that replace the HP1a CTE
charged residues with neutral residues result in a loss of partner
FIGURE 7. HP1a-CSD-CTE residue Leu-165 is critical for selective highaffinity binding of HP2. A, x-ray structure of HP1a-CSD-CTE (PDB 3P7J) with
dotted spheres highlighting the positions of Leu-165 and Val-171. B and C,
fluorescence polarization binding curves for HP2 (B) and PIWI (C) for the WT
and mutant forms of the HP1a-CSD-CTE. The fraction of peptide bound is
plotted as a function of HP1a-CSD-CTE dimer. D, table of the dissociation
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constant values demonstrating the selective impact that L165K has on binding. E, far UV circular dichroism spectra of HP1a-CSD-CTE WT, L165K, and
V171K, show that these residues when mutated do not significantly alter secondary structure.
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principle of differential contact points in the HP1a CSD dimer
that impart differential affinity among the partner proteins.
Finally, the beta strands of the partner proteins that interact
with the dimerization interface of the CSD also have a highly
variable sequence, and the PXVXL motif itself is variable, both
of which provide another potential means of regulating partner
affinity. Swapping the PXVXL motif between the HP2 (LSVKI)
and PIWI (PRVKV) peptides, and measuring binding to the
L165K mutant HP1a CSD-CTE eliminates the remaining differential affinity observed between HP2 and PIWI (Fig. 8). Thus
the differential roles of the HP1 paralogs can in part be traced to
their binding surface.
The work presented herein focuses on the binding surface for
proteins generated by the CSD and the region C-terminal to
it. At the N-terminal end of the protein, the CD has been
implicated in H3K9me2/3 binding. While interaction with
H3K9me2/3 clearly stabilizes HP1a at the pericentric heterochromatin and other domains where this mark is enriched, it is
not the only determinant of HP1a distribution (6). Further,
HP1a, HP1b, and HP1c do not distribute coincidently (5). The
chromo shadow domain could play a role by interacting with
DNA-binding proteins that localize to specific regions in the
DNA. For example HP1c binds to WOC, which is a DNA binding zinc finger protein (23, 24). HP1a binds to Su(var)3–7,
which also has DNA binding activity (26). Thus the specificity
of the CSD in partner selection may play an important role in
determining the distribution of the paralogs. More work is
needed understand the significance of those interactions.
Although we are learning more about CSD function, there
are still many open questions. By understanding the mechanisms in place to discriminate between different partners,
including the CSD binding partners that have DNA binding
activity as well as those with other functions, we will be able to
gain a fuller understanding of the roles that the HP1 paralogs,
and HP1a in particular, are playing in the genome.

FIGURE 8. The HP1a-CSD-CTE-L165K peptide in conjunction with a pentamer swap between HP2 and PIWI imparts equivalent binding of HP2
and PIWI. A, pentamer exchange between HP2 and PIWI. B and C, fluorescence polarization binding curves for HP1a-CSD-CTE WT and the L165K
mutated peptide with HP2 (B) and PIWI (C) using either the WT or pentamerswapped counterpart in the latter case. D, table of the dissociation constant
values demonstrating the equivalent binding of the pentamer-swap peptides to the L165K mutant CDS.

binding affinity (Fig. 5), confirming the importance of the
charged CTE for HP1a function. In contrast, the addition of the
neutral CTE to the HP1b CSD weakens dimerization (Fig. 3);
this change results in similar or decreased peptide binding
affinity (Fig. 4). Thus the characteristics of the CTE contribute
to the ability of HP1a to bind to HP2 (an essential heterochromatin protein) with high affinity compared with the binding by
HP1b (Figs. 2, 4, 5).
We also investigated the residues in HP1a outside of the
dimerization interface that might allow for the observed differential affinity for HP2 and PIWI. Leu-165 proved to be a critical
player, impacting binding of the HP2 peptide but not the PIWI
peptide (Figs. 6 and 7). The results with Leu-165 establish the
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